0001213900-18-013226.txt : 20180928
0001213900-18-013226.hdr.sgml : 20180928
20180928170703
ACCESSION NUMBER: 0001213900-18-013226
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180927
FILED AS OF DATE: 20180928
DATE AS OF CHANGE: 20180928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pearson Mark E.
CENTRAL INDEX KEY: 0001486558
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 181094865
MAIL ADDRESS:
STREET 1: 3031 TISCH WAY
STREET 2: SUITE 505
CITY: SAN JOSE
STATE: CA
ZIP: 95128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2018-09-27
0
0000812796
SOLIGENIX, INC.
SNGX
0001486558
Pearson Mark E.
29 EMMONS DRIVE, SUITE B-10
PRINCETON
NJ
08540
1
0
1
0
Stock Option (Right to Buy)
1.67
2018-09-27
4
A
0
17964
0
A
2028-09-26
Common Stock
17964
17964
D
The stock option vests ratably on each of December 27, 2018, March 27, 2019, June 27, 2019 and September 27, 2019.
/s/ Mark E. Pearson
2018-09-28